Synairgen Research Ltd.

🇬🇧United Kingdom
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.synairgen.com

Pilot Test of COVID-19 Related Clinical Outcome Assessment Methodology and Qualitative Evidence of Content Validity

Completed
Conditions
First Posted Date
2022-01-26
Last Posted Date
2023-01-04
Lead Sponsor
Synairgen Research Ltd.
Target Recruit Count
29
Registration Number
NCT05207293
Locations
🇬🇧

Hull Royal Infirmary, Hull, East Riding Of Yorkshire, United Kingdom

🇺🇸

Henry Ford Health System, Detroit, Michigan, United States

🇬🇧

University Hospitals Dorset NHS Foundation Trust, Bournemouth, Dorset, United Kingdom

and more 2 locations

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19

First Posted Date
2021-02-01
Last Posted Date
2023-03-27
Lead Sponsor
Synairgen Research Ltd.
Target Recruit Count
623
Registration Number
NCT04732949
Locations
🇧🇷

Instituto Mederi de Pesquisa e Saúde, Passo Fundo, Rio Grande Do Sul, Brazil

🇲🇽

Hospital General de Culiacan D, Culiacan, Sinaloa, Mexico

🇲🇽

Hospital General Regional O´Hu, Merida, Yucatán, Mexico

and more 109 locations

Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection

Phase 2
Completed
Conditions
Interventions
First Posted Date
2020-05-12
Last Posted Date
2023-01-04
Lead Sponsor
Synairgen Research Ltd.
Target Recruit Count
221
Registration Number
NCT04385095
Locations
🇬🇧

Hull and East Yorkshire NHS Trust, Castle Hill Hospital,, Hull, United Kingdom

🇬🇧

City Campus of Nottingham University, Nottingham, United Kingdom

🇬🇧

Belfast City Hospital, Belfast, United Kingdom

and more 10 locations

A Study to Test a Potential New Treatment for COPD Patients Suffering From the Common Cold or Influenza

First Posted Date
2018-06-27
Last Posted Date
2023-01-04
Lead Sponsor
Synairgen Research Ltd.
Target Recruit Count
122
Registration Number
NCT03570359
Locations
🇬🇧

Queen Elizabeth Hospital, Birmingham, United Kingdom

🇬🇧

Celerion, Belfast, United Kingdom

🇬🇧

Bradford Royal Infirmary, Bradford, United Kingdom

and more 13 locations

Comparing Efficacy and Safety of Inhaled SNG001 to Placebo

Phase 2
Completed
Conditions
Interventions
First Posted Date
2010-05-19
Last Posted Date
2012-02-13
Lead Sponsor
Synairgen Research Ltd.
Target Recruit Count
300
Registration Number
NCT01126177
Locations
🇬🇧

Southampton University General Hospital, Southampton, Hampshire, United Kingdom

© Copyright 2024. All Rights Reserved by MedPath